Sign In
Buy SMTI
$20.97
-0.290 (-1.36%)
At Close: Jun 03, 2026
INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC
01:59pm, Monday, 24'th Nov 2025
ATLANTA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Sanara MedTech Inc. (“Sanara” or “the Company”) (NASDAQ: SMTI) complied with federal securities laws. O
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sanara MedTech Inc. (“S
Sanara MedTech Inc. (SMTI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
09:00am, Thursday, 20'th Nov 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) investors concerning the C
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) on behalf of investors concerning th
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd
07:30am, Wednesday, 19'th Nov 2025
FORT WORTH, TX, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on develo
Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates
10:35am, Wednesday, 12'th Nov 2025
Sanara MedTech Inc. (SMTI) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of a loss of $0.24 per share. This compares to a loss of $0.34 per share a year ago
Sanara MedTech Inc. (SMTI) Q3 2025 Earnings Call Transcript
10:01am, Wednesday, 12'th Nov 2025
Sanara MedTech Inc. ( SMTI ) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Company Participants Seth Yon - President, CEO & Director Elizabeth Taylor - Chief Financial Officer Conference Call Pa
Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited)
07:00am, Wednesday, 12'th Nov 2025
Net Revenue Increased 22% Year-Over-Year in Q3; Increased 25% Year-Over-Year in First Nine Months of 2025 FORT WORTH, TX, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “C
Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business
04:05pm, Tuesday, 11'th Nov 2025
Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our
Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025
07:30am, Wednesday, 01'st Oct 2025
FORT WORTH, TX, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing trans
Sanara MedTech: Growth Remains Strong As Debt Concerns Recede
02:46pm, Thursday, 04'th Sep 2025
SMTI's Surgical segment revenue grew 28% year-over-year in Q1 to $25.8 million. Surgical segment adjusted EBITDA was $4.7 million, while THP correspondingly posted a loss of $2.1 million. Management i
Sanara MedTech Inc. Announces Chief Executive Officer Transition
04:30pm, Tuesday, 02'nd Sep 2025
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
04:05pm, Wednesday, 27'th Aug 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on develop
Sanara MedTech Inc. (SMTI) Q2 2025 Earnings Call Transcript
12:18pm, Wednesday, 13'th Aug 2025
Sanara MedTech Inc. (NASDAQ:SMTI ) Q2 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants Elizabeth B. Taylor - Chief Financial Officer Ronald T.
Sanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue Estimates
09:26am, Wednesday, 13'th Aug 2025
Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.41 per share a year ago.
